Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 589 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 92% confidence The document is titled “분기보고서” (Quarterly Report) for the 25th fiscal period covering January 1, 2026 to March 31, 2026. It includes full financial statements, tables of capital and share information, business summaries, credit ratings, capital changes, and detailed narrative on operations. This is a comprehensive interim (quarterly) financial report, not merely an announcement or summary. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 95% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It contains detailed information about share ownership, changes in holdings, and securities owned by executives and major shareholders of the company Vivozon Inc. The document includes dates, share counts, ownership percentages, and transaction details. This type of filing corresponds to notifications about significant share ownership changes or insider holdings. It is not an annual report, earnings release, or management report. It is specifically about share ownership by insiders and major shareholders, which matches the definition of 'Major Shareholding Notification' (Code: MRQ). The document length is 2566 characters, which is consistent with a detailed ownership notification rather than a full financial report or announcement. Therefore, the correct classification is MRQ with high confidence.
2026-05-07 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제15회차)
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the acquisition of convertible bonds (including overseas convertible bonds) before maturity by the company. It includes specific financial details such as bond issuance date, acquisition amount, maturity date, and reasons for acquisition. The content focuses on capital structure changes related to bond issuance and repurchase. There is no indication that this is a full financial report, audit, or earnings release. The document is not a brief announcement of a report publication but a substantive update on financing activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2158 characters, which is sufficient for a detailed announcement but not a full report.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an executive’s acquisition/disposition of company shares with specific dates, quantities, and insider details. This matches an insider trading report by a director or officer. Therefore, it falls under Director’s Dealing (DIRS).
2026-04-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서,” which discloses an officer’s and major shareholder’s specific securities holdings, percentage ownership, and detailed acquisition/disposal transactions. This matches an insider transaction report by directors/executives. Therefore, it is classified as a Director’s Dealing filing.
2026-04-15 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 90% confidence The document is titled “자기주식처분결과보고서” (Report on disposal of treasury stock) filed to the Financial Supervisory Service and provides detailed data on the sale/disposal of the company’s own shares (dates, share counts, prices, post‐disposal holdings). This clearly corresponds to a Transaction in Own Shares report.
2026-04-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.